(Z)-N-benzylidene-2-(tert-butoxycarbonylamino)-1-(5-bromo-1H-indol-3-yl)ethanamine N-oxide | 1044516-32-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (Z)-N-benzylidene-2-(tert-butoxycarbonylamino)-1-(5-bromo-1H-indol-3-yl)ethanamine N-oxide
• 英文别名: N-[1-(5-bromo-1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]-1-phenylmethanimine oxide
• CAS: 1044516-32-6
• 化学式: C₂₂H₂₄BrN₃O₃
• 分子量: 458.355
• InChiKey: JOLDXWNGVJNHLN-WGARJPEWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  82.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (Z)-N-benzylidene-2-(tert-butoxycarbonylamino)-1-(5-bromo-1H-indol-3-yl)ethanamine N-oxide 在 盐酸羟胺 、 三氯化钛 作用下， 以 甲醇 、 水 为溶剂， 反应 1.5h， 生成 tert-butyl 2-amino-2-(5-bromo-1H-indol-3-yl)ethylcarbamate
  参考文献：
  名称：

  溴化海洋海绵生物碱的总合成。

  摘要：

  描述了六种溴化的洋紫花素，海绵蛋白和托普丁素的海洋海绵状双（吲哚）生物碱的总合成。逆合成分析显示它们的结构全部包括1-（6'-溴吲哚-3'-基）-1,2-二氨基乙烷单元13a。该关键部分是通过合成中间体8b由溴化的吲哚N-羟胺5b制备的。

  DOI：

  10.1021/ol701626m
• 作为产物：
  描述：

  tert-butyl 2-(benzyl(hydroxy)amino)-2-(1H-indol-3-yl)ethylcarbamate 在 甲醇 、 manganese(IV) oxide 、 乙酰氯 作用下， 以 甲苯 为溶剂， 反应 2.08h， 生成 (Z)-N-benzylidene-2-(tert-butoxycarbonylamino)-1-(5-bromo-1H-indol-3-yl)ethanamine N-oxide
  参考文献：
  名称：

  Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents

  摘要：

  A collection of 3-substituted indole derivatives was prepared using nucleophilic addition of indoles to nitrones. The compounds were then tested for their antibacterial activity against almost thirty bacterial strains representative of common human pathogens. Two types of indolic molecules inhibit the growth of Staphylococcus aureus, including MRSA and VISA strains, with MIC values ranging from 8 to 16 mg/L. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.03.060

文献信息

• NOVEL INDOLIC DERIVATIVES, THEIR PREPARATION PROCESSES AND THEIR USES IN PARTICULAR AS ANTIBACTERIALS
  申请人：Denis Jean-Noel Marie Leon

  公开号：US20100144726A1

  公开（公告）日：2010-06-10

  The invention relates to the use of at least one compound of the formula (I), in which R and R 3 are particularly a hydrogen atom, R 1 is particularly a hydrogen atom or a methyl, ethyl or isobutyl mi group, R 4 , R 5 , R 6 and R 7 are independently a hydrogen atony, an alkoxyl group with 1 to 7 carbon atoms or a halogen atom, R 2 is a hydrogen atom, an O − group or an OH group, B is an N-GP 1 or NR c , group, GP 1 being a Boc or Cbz group, and R c is a hydrogen atom or a methyl or t-butyl group, for preparing a drug for treating conditions associated with bacterial infections, in particular for treating bacterial diseases.

  该发明涉及使用至少一种具有以下式（I）的化合物，其中R和R3特别是氢原子，R1特别是氢原子或甲基、乙基或异丁基mi基团，R4、R5、R6和R7独立地是氢原子、具有1至7个碳原子的烷氧基团或卤原子，R2是氢原子、O−基团或OH基团，B是N-GP1或NRc基团，GP1是Boc或Cbz基团，Rc是氢原子或甲基或叔丁基基团，用于制备用于治疗与细菌感染相关的疾病症状的药物，特别是用于治疗细菌性疾病。
• BIS-INDOLIC DERIVATIVES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG
  申请人：Denis Jean-Noël

  公开号：US20140309272A1

  公开（公告）日：2014-10-16

  Novel bis-indolic derivatives, processes for their preparation, and their potential use as new antibacterial drugs.

  小说双吲哚衍生物，其制备过程以及它们作为新型抗菌药物的潜在用途。
• BIS-INDOLIC DERIVATIVES, THEIR USES IN PARTICULAR AS ANTIBACTERIALS
  申请人：Denis Jean-Noël

  公开号：US20140228359A1

  公开（公告）日：2014-08-14

  The present invention relates to novel bis-indolic derivatives, processes for their preparation, and their potential use as new antibacterial drugs.

  本发明涉及新型双吲哚衍生物、其制备方法及其作为新型抗菌药物的潜在用途。
• NOVEL BIS-INDOLIC DERIVATIVES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG
  申请人：Université Joseph Fourier

  公开号：EP2548864B1

  公开（公告）日：2014-02-19
• Novel bis-indolic derivatives, their uses in particular as antibacterials
  申请人：Université Joseph Fourier

  公开号：EP2548865B1

  公开（公告）日：2014-03-05